Eurepa-V
Eurepa-V Products are primarily used for
About Eurepa-V Products
Uses of Eurepa-V Products
Repaglinide+Voglibose is used in the treatment of type 2 diabetes mellitus.
Eurepa-V Products side effects
Common
Side Effects of Eurepa-V are Flatulence, Diarrhea, Stomach pain, Hypoglycemia (low blood glucose level), Skin rash, Abdominal pain, Upper respiratory tract infection, Headache.
How Eurepa-V Products work
Repaglinide + Voglibose is a combination of two antidiabetic medicines: Repaglinide and voglibose. Repaglinide is a meglitinide analogue which increases the amount of insulin released by the pancreas. Voglibose is an alpha-glucosidase inhibitor which inhibits the intestinal enzymes that cause breakdown of complex sugars into simple sugars such as glucose. Together, they prevent blood sugar from rising very high after meals.
Products for Eurepa-V
MRP
₹140.7
Not Available
MRP
₹181.4
Not Available
MRP
₹140.7
Not Available
MRP
₹181.4
Not Available
Substitute brands for Eurepa-V
Mega V
Eris Lifesciences Ltd
1 Product
Volga R
Ajanta Pharma Ltd
5 Products
Vogli-Rapid
Medley Pharmaceuticals
4 Products
Volix R
Sun Pharmaceutical Industries Ltd
4 Products
Voglimac R
Macleods Pharmaceuticals Pvt Ltd
4 Products